Neocis’ Yomi platform completes over 100,000 osteotomies
Yomi S has a smaller footprint than Neocis’ first system and features a longer arm to make it more flexible in tight spaces. | Source: Neocis
Neocis Inc. yesterday said that clinicians have completed more than 100,000 osteotomies using the Yomi platform. The company also confirmed that the first clinical cases using Yomi S, its second-generation robotic system, have now been successfully completed by Dr. Jay Neugarten, DDS, MD, FACS.
“Reaching 100,000 osteotomies is more than just a statistical achievement — it represents clinicians across the country choosing to integrate robotics into their daily surgical workflow,” said Alon Mozes, co-founder and CEO of Neocis. “This level of usage demonstrates trust in the technology and reinforces our belief that robotics has set a new standard of care.”
Founded in 2009, Neocis said it aims to bring robotics to the field of dental surgery. The Miami-based company collaborates with clinicians to develop technologies that help advance patient care and improve quality of life for physicians and patients.
Neocis system helps dentists stay on track
The Yomi platform combines real-time haptic guidance, pre-operative digital planning, and intra-operative adaptability to assist clinicians during implant cases, said Neocis. Since its introduction, Yomi has been used in a wide variety of cases, from single-tooth to full-arch implant procedures.
The system includes YomiPlan AI to help plan dental procedures. It uses proprietary machine learning algorithms that automate the segmentation of critical anatomy, like nerves and sinuses, from cone beam computer tomography (CBCT) scans.
“Clinicians are increasingly seeking technologies that integrate seamlessly into existing workflows while delivering tangible procedural value,” said Dennis Moses, chief technology officer of Neocis. “The scale reflected in 100,000 osteotomies validates both the robustness of the platform and its proven ability to perform consistently across real-world clinical environments.”
The U.S. Food and Drug Administration (FDA) has cleared Yomi for robot-assisted dental surgery. Neocis said it was the first company to achieve FDA-clearance for a robotic system for dental implant surgery.
Yomi S delivers enhanced dexterity
Neocis unveiled Yomi S in November 2025. The company said the system uses YomiPlan to deliver surgical precision, streamlined workflows, and high-quality patient outcomes. The system has a smaller footprint, enhanced dexterity, and improved visibility compared with its predecessor.
“So you can plan the case in software using our AI-enabled planning. We can automatically find the nerve for you,” Moses told The Robot Report when Neocis released Yomi S. “We can automatically find the sinus and get it so that you can plan the case as close to perfect as possible. Then the robot guides them to get exactly what they planned in software.”
“It works with the dentist hand in hand, using physical guidance with haptics as well as kind of visual and audio cues on the screen,” he added. “It’s kind of like Lane Assist; they have to color inside the lines. They can only drill according to the plan they made preoperatively.”
Neocis said it continues to invest in expanding Yomi’s capabilities through software enhancements, workflow optimization, and advanced planning tools designed to support efficient case execution and broaden clinical applications.
The post Neocis’ Yomi platform completes over 100,000 osteotomies appeared first on The Robot Report.